与传感器增强疗法相比,使用无管自动胰岛素输送系统的1型糖尿病成年人的心理社会结果:一个随机的平行组临床试验子研究
Jean-Pierre Riveline1,2, Eric Renard3, Grazia Aleppo4
1Department of Endocrinology and Diabetology, Lariboisière Hospital, APHP and Paris Cité University, Paris, France.
Diabetes, obesity & metabolism
|January 9, 2026
概括
与传感器增强疗法相比,自动化胰岛素输送 (AID) 系统显著改善了1型糖尿病成年人的心理社会结果. 这种无管的AID系统提高了生活质量,降低了糖尿病负担.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病 技术 技术
- 心理社会健康 心理健康
背景情况:
- 自动化胰岛素输送系统 (AID) 在1型糖尿病 (T1D) 管理中提供了超出血糖控制的好处.
- 心理社会福祉和生活质量是与T1D生活的关键方面.
研究的目的:
- 评估使用无管Omnipod® 5 AID系统的心理社会结果.
- 将这些结果与T1D成年人的传感器增强 (SAP) 治疗进行比较.
主要方法:
- 一项为期13周的多中心,随机对照试验,涉及患有T1D的成年人 (18-70岁).
- 参与者填写了关于生活质量 (EQ-5D-3L),糖尿病影响 (DIDP),睡眠质量 (PSQI) 和系统可用性 (SUS,INSPIRE) 的验证问卷.
主要成果:
- 与SAP组相比,无管AID组在与健康有关的生活质量 (EQ-5D-3L VAS和指数),糖尿病影响 (DIDP),系统可用性 (SUS) 和睡眠质量 (PSQI) 上显示出更大的改善.
- 高基线和后续INSPIRE分数表明对无管AID系统的积极看法.
结论:
- 与T1D成年人的SAP治疗相比,无管Omnipod® 5 AID系统显著改善了心理社会措施.
- 这些发现支持AID系统在提高生活质量和减轻糖尿病自我管理负担方面的作用.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
673
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
673
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Insulin Formulations: Types and Delivery
642
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
642


